Trxade Health Inc
MEDS
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.22M
Close$
$-9.43
732.7% downside
Current Fair Value
732.7% downsideOvervalued by 732.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.22 Million |
|---|---|
| Enterprise Value | $-3,527,529,124.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-71.5 |
| Beta | -1.52 |
| Outstanding Shares | 1,419,724 |
Return
| Return on Equity | -67.21% |
|---|---|
| Return on Assets | -55.68% |
| Return on Invested Capital | -60.38% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -7.23 |
| Enterprise Value to EBIT | 0.08 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data